Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook

Health, Fitness & Food

Eli Lilly’s office in La Jolla, California.
Konrad Fiedler | Bloomberg | Getty Images

The launch of Eli Lilly‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday.

Products You May Like

Articles You May Like

Beef Barley Soup
How the FDA’s approval for food additives works, and why experts say a loophole allows companies to bypass it
Fitfluencers Can’t Get Enough of Hot Yoga. Are the Benefits Legit Though?
Diana Taurasi Taught Latine Basketball Fans How to Take Up Space in the World
FDA cancels vaccine advisory meeting for choosing flu strains for next season’s shots

Leave a Reply

Your email address will not be published. Required fields are marked *